Delayed treatment with AM-36, a novel neuroprotective agent, reduces delayed neuronal damage after endothelin-1 induced middle cerebral artery occlusion in conscious rats

Jennifer Kay Callaway, Melissa Knight, Dianne Watkins, Philip M Beart, Bevyn Jarrott

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Pages (from-to)2704 - 2712
Number of pages9
JournalStroke
Publication statusPublished - 1999

Cite this